Mario Giuliano

7.5k total citations
109 papers, 3.8k citations indexed

About

Mario Giuliano is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mario Giuliano has authored 109 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 41 papers in Cancer Research and 39 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mario Giuliano's work include HER2/EGFR in Cancer Research (29 papers), Advanced Breast Cancer Therapies (28 papers) and Breast Cancer Treatment Studies (23 papers). Mario Giuliano is often cited by papers focused on HER2/EGFR in Cancer Research (29 papers), Advanced Breast Cancer Therapies (28 papers) and Breast Cancer Treatment Studies (23 papers). Mario Giuliano collaborates with scholars based in Italy, United States and Spain. Mario Giuliano's co-authors include Sabino De Placido, Grazia Arpino, Rachel Schiff, Michelino De Laurentiis, Meghana V. Trivedi, Antonio Giordano, Massimo Cristofanilli, Lucia Del Mastro, Fabio Puglisi and Francesco Schettini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Mario Giuliano

104 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mario Giuliano Italy	34	2.4k	1.4k	1.2k	1.0k	351	109	3.8k
Elisabetta Munzone Italy	31	2.4k 1.0×	1.4k 1.0×	765 0.7×	611 0.6×	254 0.7×	129	3.3k
Dimitrios Zardavas Belgium	21	2.1k 0.8×	1.3k 0.9×	854 0.7×	945 0.9×	242 0.7×	69	3.3k
Erica L. Mayer United States	31	2.6k 1.1×	1.2k 0.9×	997 0.9×	1.4k 1.4×	495 1.4×	144	4.7k
Nina J. Karlin United States	15	2.2k 0.9×	1.1k 0.8×	969 0.8×	1.4k 1.4×	190 0.5×	47	4.1k
Otto Metzger United States	30	3.2k 1.3×	1.7k 1.2×	1.4k 1.2×	1.4k 1.4×	384 1.1×	117	4.8k
Shaheenah Dawood United Arab Emirates	32	3.4k 1.4×	2.3k 1.6×	1.4k 1.2×	989 1.0×	383 1.1×	109	5.1k
David R. Shalinsky United States	27	1.7k 0.7×	1.3k 0.9×	1.0k 0.9×	2.3k 2.3×	256 0.7×	52	4.3k
In Hae Park South Korea	31	2.3k 0.9×	1.4k 1.0×	1.7k 1.5×	532 0.5×	236 0.7×	114	3.6k
James Stec United States	24	2.2k 0.9×	2.0k 1.4×	602 0.5×	1.9k 1.9×	384 1.1×	40	4.6k
Romano Demicheli Italy	33	2.1k 0.9×	1.3k 0.9×	546 0.5×	710 0.7×	241 0.7×	97	3.4k

Countries citing papers authored by Mario Giuliano

Since Specialization

Citations

This map shows the geographic impact of Mario Giuliano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Giuliano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Giuliano more than expected).

Fields of papers citing papers by Mario Giuliano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Giuliano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Giuliano. The network helps show where Mario Giuliano may publish in the future.

Co-authorship network of co-authors of Mario Giuliano

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Giuliano. A scholar is included among the top collaborators of Mario Giuliano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Giuliano. Mario Giuliano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conti, Chiara, Stefania Stella, Michele Massimino, et al.. (2025). Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer. Critical Reviews in Oncology/Hematology. 214. 104834–104834. 1 indexed citations

Schettini, Francesco, et al.. (2024). Reawakening the master switches in triple-negative breast cancer: A strategic blueprint for confronting metastasis and chemoresistance via microRNA-200/205: A systematic review. Critical Reviews in Oncology/Hematology. 204. 104516–104516. 4 indexed citations

Lambertini, Matteo, Pietro De Placido, Sabino De Placido, et al.. (2024). Abstract PO4-03-07: The impact of chemotherapy relative dose intensity on pathological complete response in patients with triple negative breast cancer treated with neoadjuvant chemotherapy. Cancer Research. 84(9_Supplement). PO4–3. 1 indexed citations

Pepe, Francesco, Jole Ventriglia, Giancarlo Troncone, et al.. (2024). Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type. Frontiers in Oncology. 14. 1412807–1412807. 3 indexed citations

Maïo, Massimo Di, Claudia Bighin, Francesco Schettini, et al.. (2023). Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study. The Breast. 72. 103583–103583. 5 indexed citations

Rizzo, Alessandro, Francesco Di Costanzo, Silvana Acquafredda, et al.. (2023). Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis. ESMO Open. 8(6). 102198–102198. 12 indexed citations

Pelosio, L, Luigi Camera, Massimo Imbriaco, et al.. (2023). R0 surgical resection of giant dedifferentiated retroperitoneal liposarcomas in the COVID era with and without nephrectomy: A case report. Oncology Letters. 26(3). 410–410. 2 indexed citations

Cennamo, Gilda, Gilda Cennamo, Daniela Montorio, et al.. (2022). Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy. Frontiers in Oncology. 11. 754108–754108. 11 indexed citations

Arx, Claudia von, Pietro De Placido, Michelino De Laurentiis, et al.. (2022). The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Reviews. 113. 102500–102500. 64 indexed citations

10.

Napolitano, Fabiana, Pietro De Placido, Valeria Forestieri, et al.. (2022). Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer. Biomolecules. 12(10). 1394–1394. 12 indexed citations

11.

Marra, Maurizio, Iolanda Cioffi, Lidia Santarpia, et al.. (2022). Prevalence of Sarcopenia in Women with Breast Cancer. Nutrients. 14(9). 1839–1839. 19 indexed citations

12.

Montella, Liliana, Margaret Ottaviano, Gaetano Facchini, et al.. (2021). Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling. Biomedicines. 9(12). 1759–1759. 2 indexed citations

13.

Lambertini, Matteo, Francesca Poggio, Marco Bruzzone, et al.. (2019). Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. International Journal of Cancer. 147(1). 160–169. 11 indexed citations

14.

Giuliano, Mario, Hin Ching Lo, Grazia Arpino, et al.. (2018). Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize. Cancer Research. 78(4). 845–852. 153 indexed citations

15.

Placido, Sabino De, Mario Giuliano, Francesco Schettini, et al.. (2018). Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results. The Breast. 38. 86–91. 20 indexed citations

16.

Buono, Giuseppe, Mario Giuliano, Carmine De Angelis, et al.. (2017). Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study. Clinical Breast Cancer. 17(7). 559–563. 12 indexed citations

17.

Malorni, Luca, Mario Giuliano, Ilenia Migliaccio, et al.. (2016). Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance. Molecular Cancer Research. 14(5). 470–481. 31 indexed citations

18.

Damato, Valentina, Lucia Raimondo, Luigi Formisano, et al.. (2015). Mechanisms of lapatinib resistance in HER2-driven breast cancer. Cancer Treatment Reviews. 41(10). 877–883. 128 indexed citations

19.

Morrison, Gladys, Xiaoyong Fu, Martin J. Shea, et al.. (2014). Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance. Breast Cancer Research and Treatment. 144(2). 263–272. 39 indexed citations

20.

Giuliano, Mario. (1965). Il commercio internazionale.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact